Edesa Biotech, Inc.

EDSA · Nasdaq · SIC 2834: Pharmaceutical Preparations · Market Cap: $0.2B · 17 employees
321
SEC Filings
$2.76
Close 2026-10-22
17
Employees

Business Summary

Edesa Biotech is a biopharmaceutical company developing therapies for inflammatory and immune-related diseases. Its pipeline includes EB06 (anti-CXCL10 monoclonal antibody) for vitiligo, EB01 (daniluromer cream) for allergic contact dermatitis, and EB05 (paridiprubart) for Acute Respiratory Distress Syndrome (ARDS). In October 2025, paridiprubart met primary and secondary endpoints in a Phase 3 ARDS study. The company in-licenses assets from academic institutions and biopharmaceutical companies and pursues government grants and partnerships for development.

Latest Stock Quote

EDSA 2026-10-22 $2.76 O:$2.89 H:$2.99 L:$2.749 Vol:0.0M VWAP:$2.7999
origin leaf: null

Next Earnings

expected 2027-01-14

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2025-12-122025-09-300001171843-25-007914EDGAR73K words
2024-12-132024-09-300001171843-24-006946EDGAR70K words
2023-12-152023-09-300001654954-23-015632EDGAR70K words
2022-12-162022-09-300001654954-22-016633EDGAR58K words
2021-12-282021-09-300001654954-21-013551EDGAR59K words
2020-12-072020-09-300001654954-20-013236EDGAR56K words
2018-11-302018-09-300001144204-18-062614EDGAR48K words
2017-12-012017-09-300001144204-17-061791EDGAR56K words
2016-12-142016-09-300001144204-16-139528EDGAR63K words
2015-12-142015-09-300001144204-15-070753EDGAR63K words

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2026-08-132026-06-300001171843-26-005502EDGAR20K words
2026-02-132025-12-310001171843-26-000812EDGAR17K words
2025-08-082025-06-300001171843-25-005236EDGAR21K words
2025-05-142025-03-310001171843-25-003189EDGAR21K words
2025-02-142024-12-310001171843-25-000866EDGAR17K words
2024-08-092024-06-300001171843-24-004651EDGAR16K words
2024-05-102024-03-310001654954-24-005971EDGAR16K words
2024-02-092023-12-310001654954-24-001540EDGAR14K words
2023-08-092023-06-300001654954-23-010380EDGAR16K words
2023-05-112023-03-310001654954-23-006231EDGAR14K words
2023-02-102022-12-310001654954-23-001577EDGAR12K words
2022-08-122022-06-300001654954-22-011208EDGAR14K words

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-11-090001171843-26-007242EDGAR1K words
2026-10-230001171843-26-006794EDGAR1K words
2026-10-150001171843-26-006647EDGAR1K words
2026-08-200001171843-26-005686EDGAR26K words
2026-08-130001171843-26-005499EDGAR3K words
2026-02-240001171843-26-001046EDGAR2K words
2026-02-130001171843-26-000810EDGAR2K words
2025-12-120001171843-25-007918EDGAR1K words
2025-12-120001171843-25-007913EDGAR2K words
2025-10-280001171843-25-006690EDGAR1K words

321 total filings indexed. 289 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACIU — AC Immune SA ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA

Tags

medical-dermatology respiratory immuno-inflammatory-diseases occupational-skin-conditions

Company Identity

CIK0001540159
TickerEDSA
ExchangeNasdaq
SIC2834: Pharmaceutical Preparations
IncorporatedA1
Websitehttps://www.edesabiotech.com
Listed2010-06-09

Get More Data

This is a static snapshot. For live, structured JSON with cryptographic provenance chain:

MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp

JSON Profile Stock Quote Origin Record
Origin Provenance
page leaf: 81a3468957b6610d098238f7b8735ddc772a7ad54e8aec7bfbcc6af5c5c543ce
parent: ee770c9a61c0f71b9e07b11914ad961b1037034b4547dc6677901e726c570b9d
content hash: 3e0ac4804fee8dd09f0b19d5dfa0582f4d4e1a744cceb5a6bfba17dff0f2280e
signed: 2026-11-16T19:01:49.090Z
sources: 22 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf

Try it — paste this into your AI:

Look up EDSA using the MCP server at origin.rootz.global/mcp. What do their latest SEC filings show?

Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.

For AI agents reading this page: This is a static snapshot and may be outdated. For live data on EDSA, use the Origin MCP server or REST API.
MCP install: claude mcp add origin --transport http https://origin.rootz.global/mcp
API: GET https://origin.rootz.global/api/company/EDSA (~200 tokens, structured JSON with cryptographic provenance)
Tools: origin_company, origin_profile, origin_timeline, origin_filings, origin_quote, origin_transcripts, origin_search, origin_person, origin_skill
Discovery: /.well-known/ai | /llms.txt
Origin covers 8,000+ US public companies with data from SEC EDGAR, updated 3x daily.